HEAL Initiative: National K12 Clinical Pain Career Development Program (K12 Clinical Trial Not Allowed) | RFA NS 22 045

Opportunity Information: Apply for RFA NS 22 045

The HEAL Initiative: National K12 Clinical Pain Career Development Program (RFA-NS-22-045) is a National Institutes of Health (NIH) grant opportunity designed to strengthen the clinical pain research workforce by building a clearer, better supported pathway for early-career clinician-scientists to become independent investigators. The program uses a K12 institutional career development model, meaning NIH funds a national program (rather than directly funding individual applicants at the outset) that then selects and supports "scholars" who are launching their academic research careers in pain. A key purpose is to address workforce gaps in clinical pain research by pairing promising clinicians with strong mentorship, structured career development, and dedicated time and resources to establish sustainable research programs.

The focus is on clinicians who are at a pivotal transition point: those in their last year of residency, fellowship, or postdoctoral training, as well as those in their first year of an independent faculty position. Selected scholars are expected to begin receiving K12 support during their first or second year on faculty, when protected research time and credible mentorship can make the biggest difference in successfully moving from supervised training into independent funding and leadership. The program is especially aimed at supporting clinicians who leave their training institution to take a faculty position elsewhere, reflecting the reality that many early investigators need a stable, well-supported launch environment at their new institution. The announcement also leaves room for exceptions: in some circumstances, a candidate who remains at the same institution for their faculty appointment may still be eligible for support, but the primary emphasis is on transitions to a different institution.

The national program funded under this opportunity is expected to provide more than just salary support. It is intended to offer a complete career development ecosystem that includes high-quality mentorship, research support, and meaningful protected time so scholars can build a coherent research trajectory rather than squeezing research around clinical and teaching responsibilities. The intent is to help scholars generate publishable work, develop a durable research niche, and become competitive for independent funding (for example, later-stage NIH career development awards or independent research grants), all while maintaining a clinically grounded perspective on pain.

An important structural feature is the requirement for the program to establish a National Advisory Committee (NAC). The NAC is meant to create a forum where scholars can interact not only with experienced pain researchers but also with pain patients, reinforcing the idea that high-impact clinical pain research should be scientifically rigorous and closely informed by lived experience. By building this advisory structure and a broader national network of mentors and scholars, the FOA aims to create a community that can share best practices, expand collaboration across institutions, and help early-career clinicians navigate common barriers such as limited protected time, mentorship gaps, and the complexity of building multidisciplinary pain research programs.

This funding opportunity is explicitly labeled "Clinical Trial Not Allowed," which signals that while scholars may engage in clinical research relevant to pain, the activities supported under this K12 mechanism cannot include leading an NIH-defined clinical trial as part of the award-supported research plan. In practice, that generally pushes the supported work toward other forms of clinical pain investigation (for example, observational studies, mechanistic and translational human research that does not meet the NIH definition of a clinical trial, secondary data analyses, or other trial-adjacent work that remains outside the clinical trial definition), depending on NIH policy and the specifics of the proposed research.

Eligibility to apply for the institutional award is broad and includes a wide range of domestic organizations and governmental entities, such as public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and multiple levels of government (state, county, city/township, special district governments, and independent school districts), as well as federally recognized tribal governments and certain tribal organizations. The announcement also highlights interest in applications from mission-aligned institutions and organizations serving historically underrepresented communities, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations and U.S. territories or possessions. At the same time, non-U.S. entities are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible, reinforcing that the program is intended to be built and administered domestically.

Administratively, the opportunity is a discretionary grant with NIH as the sponsoring agency and is tied to HEAL (Helping to End Addiction Long-term), reflecting NIH's broader effort to address pain and related public health needs. The original closing date listed for this specific announcement was March 24, 2022, and the program is cataloged under multiple CFDA numbers (93.121, 93.213, 93.393, 93.853, 93.865, 93.866), reflecting NIH institute participation and the cross-cutting nature of pain research and workforce development. Overall, the central deliverable is a national K12 career development program that recruits and supports early-career clinical pain researchers, surrounds them with high-quality mentorship and patient-informed guidance, and gives them the time and resources needed to transition into independent academic research careers.

• The National Institutes of Health in the education, health, income security and social services sector is offering a public funding opportunity titled "HEAL Initiative: National K12 Clinical Pain Career Development Program (K12 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.213, 93.393, 93.853, 93.865, 93.866.
• This funding opportunity was created on 2022-01-10.
• Applicants must submit their applications by 2022-03-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA NS 22 045

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: